These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4546971)

  • 1. Trinidazole--a new preparation for Trichomonas vaginalis infections. I. Laboratory evaluation.
    Forsgren A; Wallin J
    Br J Vener Dis; 1974 Apr; 50(2):146-7. PubMed ID: 4546971
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of tinidazole on T. vaginalis in vitro].
    Savoia D; Martinetto P; Pugliese A
    G Batteriol Virol Immunol Microbiol; 1972 Jan; 65(1):32-8. PubMed ID: 4134002
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of 5-nitroimidazole-resistant trichomonas vaginalis in Oviedo, Spain.
    Pérez S; Fernández-Verdugo A; Pérez F; Vázquez F
    Sex Transm Dis; 2001 Feb; 28(2):115-6. PubMed ID: 11234785
    [No Abstract]   [Full Text] [Related]  

  • 4. A metronidazole-resistant strain of Trichomonas vaginalis and its sensitivity to Go 10213.
    Ray DK; Tendulkar JS; Shrivastava VB; Datta AK; Nagarajan K
    J Antimicrob Chemother; 1984 Oct; 14(4):423-6. PubMed ID: 6334072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of Trichomonas vaginalis sensitivity to nitroimidazole group preparations using solid nutrient media].
    Bednova VN; Vasil'ev MM
    Vestn Dermatol Venerol; 1982 Nov; (11):19-21. PubMed ID: 6984259
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vitro sensitivity of 50 Trichomonas vaginalis strains to CP 12 574].
    Kremer M; Miltgen F; Dellenbach P
    Rev Fr Gynecol Obstet; 1972 Nov; 67(11):655-7. PubMed ID: 4540771
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of the antitrichomonal activity of 5-nitroimidazole derivatives by hydrogen peroxide.
    Mattana A; Juliano C; Picci V; Franconi F; Cappuccinelli P
    New Microbiol; 1993 Oct; 16(4):359-65. PubMed ID: 8264426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of dicationic compounds against Trichomonas vaginalis.
    Crowell AL; Stephens CE; Kumar A; Boykin DW; Secor WE
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3602-5. PubMed ID: 15328138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'In vitro' study of chemotherapeutic activity of sulphimidazole on some sensitive and metronidazole-resistant Trichomonas vaginalis strains.
    Malagoli M; Rossi T; Baggio A; Zandomeneghi G; Zanca A; Casolari C; Castelli M
    Pharmacol Res; 2002 Nov; 46(5):469-72. PubMed ID: 12419652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of antimicrobial nitroimidazolyl 2-sulfides, -sulfoxides, and -sulfones.
    Tweit RC; Kreider EM; Muir RD
    J Med Chem; 1973 Oct; 16(10):1161-9. PubMed ID: 4201423
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacodynamics of metronidazole determined by a time-kill assay for Trichomonas vaginalis.
    Nix DE; Tyrrell R; Müller M
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1848-52. PubMed ID: 7486930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro effect of secnidazole benzoate on Trichomonas vaginalis].
    Zhang XX; Zheng SS; Zhu MM
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Apr; 27(2):111-4. PubMed ID: 19856497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole.
    Schwebke JR; Barrientes FJ
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4209-10. PubMed ID: 17000740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro effect of metronidazole ester on Trichomonas vaginalis and Entamoeba histolytica].
    He Y; Tao X; Guan L; Lian W
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(1):32-4. PubMed ID: 7788891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis.
    Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS
    Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of Trichomonas vaginalis to chemotherapeutic agents.
    Paredes FR; Hawkins DF
    J Obstet Gynaecol Br Commonw; 1973 Jan; 80(1):86-8. PubMed ID: 4540495
    [No Abstract]   [Full Text] [Related]  

  • 17. Setting a colorimetric assay with MTT for assessment of trichomonicidal activity.
    Sariego I; Monzote L; Rojas L
    Curr Clin Pharmacol; 2014; 9(3):283-7. PubMed ID: 23173972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trichomonas vaginalis: treatment and resistance to nitroimidazoles].
    Vázquez F; José García M; Pérez F; Palacio V
    Enferm Infecc Microbiol Clin; 2001 Mar; 19(3):114-24. PubMed ID: 11333589
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative in vitro cytotoxic effects of ornidazole, metronidazole and ciprofloxacin against Trichomonas vaginalis trophozoites.
    Inceboz T; Inceboz U; Ozturk S
    J Chemother; 2004 Oct; 16(5):459-62. PubMed ID: 15565912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of a new nitroimidazole derivative (CP 12 574) on 67 strains of T. vaginalis.
    Miltgen F; Dellenbach P; Kremer M
    Wiad Parazytol; 1973; 19(3):499-501. PubMed ID: 4542510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.